Cited by 690Lipid metabolism and disordersLiver Disease Diagnosis and TreatmentDiabetes, Cardiovascular Risks, and Lipoproteins

The DOI matches its Crossref record; 52 of the 53 references it cites were found in a registry or an index.

Overproduction of large VLDL particles is driven by increased liver fat content in man

Open access

Adiels, M., Taskinen, M.-R., Packard, C., Caslake, M. J., Soro-Paavonen, A., Westerbacka, J., Vehkavaara, S., Häkkinen, A., Olofsson, S.-O., Yki-Järvinen, H., Borén, J.·2006·Diabetologia

DOI 10.1007/s00125-005-0125-z

Open this paper in CoChat — free account Open PDF

Abstract

Aims/hypothesis We determined whether hepatic fat content and plasma adiponectin concentration regulate VLDL(1) production.Methods A multicompartment model was used to simultaneously determine the kinetic parameters of triglycerides (TGs) and apolipoprotein B (ApoB) in VLDL(1) and VLDL(2) after a bolus of [(2)H(3)]leucine and [(2)H(5)]glycerol in ten men with type 2 diabetes and in 18 non-diabetic men. Liver fat content was determined by proton spectroscopy and intra-abdominal fat content by MRI.Results Univariate regression analysis showed that liver fat content, intra-abdominal fat volume, plasma glucose, insulin and HOMA-IR (homeostasis model assessment of insulin resistance) correlated with VLDL(1) TG and ApoB production. However, only liver fat and plasma glucose were significant in multiple regression models, emphasising the critical role of substrate fluxes and lipid availability in the liver as the driving force for overproduction of VLDL(1) in subjects with type 2 diabetes. Despite negative correlations with fasting TG levels, liver fat content, and VLDL(1) TG and ApoB pool sizes, adiponectin was not linked to VLDL(1) TG or ApoB production and thus was not a predictor of VLDL(1) production. However, adiponectin correlated negatively with the removal rates of VLDL(1) TG and ApoB.Conclusions/interpretation We propose that the metabolic effect of insulin resistance, partly mediated by depressed plasma adiponectin levels, increases fatty acid flux from adipose tissue to the liver and induces the accumulation of fat in the liver. Elevated plasma glucose can further increase hepatic fat content through multiple pathways, resulting in overproduction of VLDL(1) particles and leading to the characteristic dyslipidaemia associated with type 2 diabetes.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1007/s00125-005-0125-z

Cites

52 of 52 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Use and Abuse of HOMA Modeling
Wallace, T. M., Levy, J. C., & Matthews, D. R. (2004) · Diabetes Care · doi:10.2337/diacare.27.6.1487 · Cited by 5,114
Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase
Yamauchi, T., Kamon, J., Minokoshi, Y., Ito, Y., Waki, H., Uchida, S., Yamashita, S., Noda, M., Kita, S., Ueki, K., et al. (2002) · Nature Medicine · doi:10.1038/nm788 · Cited by 4,238
Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease
Donnelly, K. L., Smith, C. I., Schwarzenberg, S. J., Jessurun, J., Boldt, M. D., & Parks, E. J. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23621 · Cited by 3,604
Cloning of adiponectin receptors that mediate antidiabetic metabolic effects
Yamauchi, T., Kamon, J., Ito, Y., Tsuchida, A., Yokomizo, T., Kita, S., Sugiyama, T., Miyagishi, M., Hara, K., Tsunoda, M., et al. (2003) · Nature · doi:10.1038/nature01705 · Cited by 3,176
Nonalcoholic Fatty Liver Disease
Marchesini, G., Brizi, M., Bianchi, G., Tomassetti, S., Bugianesi, E., Lenzi, M., McCullough, A. J., Natale, S., Forlani, G., & Melchionda, N. (2001) · Diabetes · doi:10.2337/diabetes.50.8.1844 · Cited by 2,581
Molecular mediators of hepatic steatosis and liver injury
Browning, J. D., & Horton, J. D. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200422422 · Cited by 1,772
Role of Fatty Acids in the Pathogenesis of Insulin Resistance and NIDDM
Boden, G. (1997) · Diabetes · doi:10.2337/diab.46.1.3 · Cited by 1,728
Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex
Cnop, M., Havel, P. J., Utzschneider, K. M., Carr, D. B., Sinha, M. K., Boyko, E. J., Retzlaff, B. M., Knopp, R. H., Brunzell, J. D., & Kahn, S. E. (2003) · Diabetologia · doi:10.1007/s00125-003-1074-z · Cited by 1,483
Banting Lecture 2001
McGarry, J. D. (2002) · Diabetes · doi:10.2337/diabetes.51.1.7 · Cited by 1,435
Disordered Fat Storage and Mobilization in the Pathogenesis of Insulin Resistance and Type 2 Diabetes
Lewis, G. F., Carpentier, A. C., Adeli, K., & Giacca, A. (2002) · Endocrine Reviews · doi:10.1210/edrv.23.2.0461 · Cited by 1,370

Show all 53 references

Research works printed but not linked: 2

World Health Organization (1999) Report of a WHO Consultation. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus. Department of Noncommunicable Disease Surveillance. World Health Organization, Geneva
Lindgren F, Jensen L (1972) The isolation and quantitative analysis of serum lipoproteins. In: Nelson GJ (ed.) Blood lipids and lipoproteins: quantification, composition and metabolism. Wiley, Livermore, CA, pp 182–217

Sorted by citations

Items 201–300 of 689

Novel metabolic classification for extrahepatic complication of metabolic associated fatty liver disease: A data-driven cluster analysis with international validation
Ye, J., Zhuang, X., Li, X., Gong, X., Sun, Y., Wang, W., Feng, S., Wu, T., & Zhong, B. (2022) · Metabolism · doi:10.1016/j.metabol.2022.155294 · Cited by 61
The challenges for molecular nutrition research 2: quantification of the nutritional phenotype
van Ommen, B., Keijer, J., Kleemann, R., Elliott, R. M., Drevon, C. A., McArdle, H. J., Gibney, M. J., & Müller, M. M. (2008) · Genes & Nutrition · doi:10.1007/s12263-008-0084-3 · Cited by 61
Adipose tissue inflammation and liver fat in patients with highly active antiretroviral therapy-associated lipodystrophy
Sevastianova, K., Sutinen, J., Kannisto, K., Hamsten, A., Ristola, M. A., & Yki‐Järvinen, H. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90224.2008 · Cited by 61
Self-citation
Postprandial hypertriglyceridaemia revisited in the era of non-fasting lipid profile testing: a 2019 Expert Panel Statement, Main Text
Kolovou, G. D., Watts, G. F., Mikhailidis, D. P., Pérez-Martínez, P., Mora, S., Bilianou, H., Panotopoulos, G., Katsiki, N., Ooi, T. C., Lopez-Miranda, J., et al. (2019) · Current Vascular Pharmacology · doi:10.2174/1570161117666190507110519 · Cited by 61
Mitochondria‐Mediated Pathogenesis and Therapeutics for Non‐Alcoholic Fatty Liver Disease
Li, Z., Li, Y., Zhang, H., Guo, J., Lam, C. W. K., Wang, C., & Zhang, W. (2019) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201900043 · Cited by 64
Fatty Liver Is Independently Associated With Alterations in Circulating HDL2 and HDL3 Subfractions
Kantartzis, K., Rittig, K., Čegan, A., Machann, J., Schick, F., Balletshofer, B. M., Fritsche, A., Schleicher, E. D., Häring, H., & Stefan, N. (2008) · Diabetes Care · doi:10.2337/dc07-1558 · Cited by 60
Dietary carnosic acid suppresses hepatic steatosis formation via regulation of hepatic fatty acid metabolism in high-fat diet-fed mice
Park, M.-Y., & Mun, S. T. (2013) · Nutrition Research and Practice · doi:10.4162/nrp.2013.7.4.294 · Cited by 59
Lipolysis, and Not Hepatic Lipogenesis, Is the Primary Modulator of Triglyceride Levels in Streptozotocin-Induced Diabetic Mice
Willecke, F., Scerbo, D. A., Nagareddy, P. R., Obunike, J. C., Barrett, T. J., Abdillahi, M., Trent, C. M., Huggins, L. A., Fisher, E. A. A., Drosatos, K., et al. (2014) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.114.304615 · Cited by 59
Prandial Hypertriglyceridemia in Metabolic Syndrome Is Due to an Overproduction of Both Chylomicron and VLDL Triacylglycerol
Shojaee‐Moradie, F., Ma, Y., Lou, S., Hovorka, R., & Umpleby, A. M. (2013) · Diabetes · doi:10.2337/db13-0935 · Cited by 59
High prevalence of apolipoprotein B dyslipoproteinemias in non-alcoholic fatty liver disease: The lifelines cohort study
Nass, K. J., van den Berg, E. H., Faber, K. N., Schreuder, T. C. M. A., Blokzijl, H., & Dullaart, R. P. F. (2017) · Metabolism · doi:10.1016/j.metabol.2017.04.004 · Cited by 58
Non‐alcoholic fatty liver disease
Tuyama, A. C., & Chang, C. (2012) · Journal of Diabetes · doi:10.1111/j.1753-0407.2012.00204.x · Cited by 58
Nonalcoholic Fatty Liver Disease as the Transducer of Hepatic Oversecretion of Very-Low-Density Lipoprotein–Apolipoprotein B-100 in Obesity
Chan, D. C., Watts, G. F., Gan, S. K., Wong, A. T. Y., Ooi, E. M. M., & Barrett, P. H. R. (2010) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.109.202275 · Cited by 57
Protein kinase STK25 controls lipid partitioning in hepatocytes and correlates with liver fat content in humans
Amrutkar, M., Kern, M., Nuñez‐Durán, E., Ståhlman, M., Cansby, E., Chursa, U., Stenfeldt, E., Borén, J., Blüher, M., & Mahlapuu, M. (2015) · Diabetologia · doi:10.1007/s00125-015-3801-7 · Cited by 57
Self-citation
Thematic review series: Patient-Oriented Research. What we have learned about VLDL and LDL metabolism from human kinetics studies
Parhofer, K. G., & Barrett, P. H. R. (2006) · Journal of Lipid Research · doi:10.1194/jlr.r600013-jlr200 · Cited by 56
Plant Stanol Esters Lower Serum Triacylglycerol Concentrations via a Reduced Hepatic VLDL‐1 Production
Plat, J., & Mensink, R. P. (2009) · Lipids · doi:10.1007/s11745-009-3361-z · Cited by 55
The RNA-binding protein vigilin regulates VLDL secretion through modulation of Apob mRNA translation
Mobin, M. B., Gerstberger, S., Teupser, D., Campana, B., Charisse, K., Heim, M. H., Manoharan, M., Tuschl, T., & Stoffel, M. (2016) · Nature Communications · doi:10.1038/ncomms12848 · Cited by 55
Investigation of human apoB48 metabolism using a new, integrated non-steady-state model of apoB48 and apoB100 kinetics
Björnson, E., Packard, C. J., Adiels, M., Andersson, L., Matikainen, N., Söderlund, S., Kahri, J., Sihlbom, C., Thorsell, A., Zhou, H., et al. (2019) · Journal of Internal Medicine · doi:10.1111/joim.12877 · Cited by 54
Self-citation
Liraglutide Increases the Catabolism of Apolipoprotein B100–Containing Lipoproteins in Patients With Type 2 Diabetes and Reduces Proprotein Convertase Subtilisin/Kexin Type 9 Expression
Vergès, B., Duvillard, L., Pais de Barros, J. P., Bouillet, B., Baillot-Rudoni, S., Rouland, A., Petit, J. M., Degrace, P., & Demizieux, L. (2021) · Diabetes Care · doi:10.2337/dc20-1843 · Cited by 54
Berry meals and risk factors associated with metabolic syndrome
Lehtonen, H.-M., Suomela, J., Tahvonen, R., Vaarno, J., Venojärvi, M., Viikari, J., & Kallio, H. P. T. (2010) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2010.27 · Cited by 56
Circulating IGFBP-2 levels are incrementally linked to correlates of the metabolic syndrome and independently associated with VLDL triglycerides
Carter, S., Li, Z., Lemieux, I., Alméras, N., Tremblay, A., Bergeron, J., Poirier, P., Deshaies, Y., Després, J., & Picard, F. (2014) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2014.09.022 · Cited by 53
Low-Normal Thyroid Function and Novel Cardiometabolic Biomarkers
van Tienhoven‐Wind, L. J. N., & Dullaart, R. P. F. (2015) · Nutrients · doi:10.3390/nu7021352 · Cited by 54
Induction of non-alcoholic fatty liver disease and insulin resistance by feeding a high-fat diet in rats: does coenzyme Q monomethyl ether have a modulatory effect?
Safwat, G. M., Pisanò, S., D’Amore, E., Borioni, G., Napolitano, M., Kamal, A. A., Ballanti, P., Botham, K. M., & Bravo, E. (2009) · Nutrition · doi:10.1016/j.nut.2009.02.009 · Cited by 51
Nonalcoholic Fatty Liver Disease: Epidemiology, Pathogenesis, Natural History, Diagnosis, and Current Treatment Options
Banini, B. A., & Sanyal, A. J. (2016) · Clinical Medicine Insights Therapeutics · doi:10.4137/cmt.s18885 · Cited by 52
Nuclear Receptors in Nonalcoholic Fatty Liver Disease
López-Velázquez, J. A., Carrillo-Córdova, L. D., Chávez-Tapia, N. C., Uribe, M., & Méndez-Sánchez, N. (2012) · Journal of Lipids · doi:10.1155/2012/139875 · Cited by 48
Sex- and Age-Specific Optimal Anthropometric Indices as Screening Tools for Metabolic Syndrome in Chinese Adults
Zhang, J., Zhu, W., Qiu, L., Huang, L., & Fang, L. (2018) · International Journal of Endocrinology · doi:10.1155/2018/1067603 · Cited by 53
Overnutrition, Hyperinsulinemia and Ectopic Fat: It Is Time for A Paradigm Shift in the Management of Type 2 Diabetes
Janssen, J. A. M. J. L. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25105488 · Cited by 70
AMPK activation caused by reduced liver lactate metabolism protects against hepatic steatosis in MCT1 haploinsufficient mice
Carneiro, L., Asrih, M., Repond, C., Sempoux, C. L., Stehle, J., Leloup, C., Jornayvaz, F. R., & Pellerin, L. (2017) · Molecular Metabolism · doi:10.1016/j.molmet.2017.10.005 · Cited by 46
Hepatic senescence marker protein-30 is involved in the progression of nonalcoholic fatty liver disease
Park, H., Ishigami, A., Shima, T., Mizuno, M., Maruyama, N., Yamaguchi, K., Mitsuyoshi, H., Minami, M., Yasui, K., Itoh, Y., et al. (2009) · Journal of Gastroenterology · doi:10.1007/s00535-009-0154-3 · Cited by 48
The genetic interactions between non-alcoholic fatty liver disease and cardiovascular diseases
Chew, N., Chong, B., Ng, C. H., Kong, G., Chin, Y. H., Xiao, W., Lee, C. J. M., Dan, Y. Y., Muthiah, M. D., & Foo, R. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.971484 · Cited by 49
Desmosterol in Human Nonalcoholic Steatohepatitis
Simonen, M., Männistö, V., Leppänen, J., Kamińska, D., Kärjä, V. J., Venesmaa, S., Käkelä, P., Kuusisto, J., Gylling, H., Laakso, M., et al. (2013) · Hepatology · doi:10.1002/hep.26342 · Cited by 49
Non-alcoholic fatty liver disease and subclinical atherosclerosis: A comparison of metabolically- versus genetically-driven excess fat hepatic storage
Costanzo, A. D., D’Erasmo, L., Polimeni, L., Baratta, F., Coletta, P., Martino, M. D., Loffredo, L., Perri, L., Ceci, F., Montali, A., et al. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2016.12.018 · Cited by 48
Serine/threonine protein kinase 25 antisense oligonucleotide treatment reverses glucose intolerance, insulin resistance, and nonalcoholic fatty liver disease in mice
Nuñez‐Durán, E., Aghajan, M., Amrutkar, M., Sütt, S., Cansby, E., Booten, S. L., Watt, A. T., Ståhlman, M., Stefan, N., Häring, H., et al. (2017) · Hepatology Communications · doi:10.1002/hep4.1128 · Cited by 49
Self-citation
Type 2 diabetes subgroups and potential medication strategies in relation to effects on insulin resistance and beta-cell function: A step toward personalised diabetes treatment?
Veelen, A., Erazo‐Tapia, E., Oscarsson, J., & Schrauwen, P. (2020) · Molecular Metabolism · doi:10.1016/j.molmet.2020.101158 · Cited by 50
A Mediterranean-style low-glycemic-load diet increases plasma carotenoids and decreases LDL oxidation in women with metabolic syndrome
Barona, J., Jones, J. J., Kopec, R. E., Comperatore, M., Andersen, C. J., Schwartz, S. J., Lerman, R. H., & Fernández, M. L. (2011) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2011.02.016 · Cited by 47
Hepatic fatty acid synthesis and partitioning: the effect of metabolic and nutritional state
Hodson, L. (2018) · Proceedings of The Nutrition Society · doi:10.1017/s0029665118002653 · Cited by 49
Assessment of the variations in fat content in normal liver using a fast MR imaging method in comparison with results obtained by spectroscopic imaging
Irwan, R., Edens, M. A., & Sijens, P. E. (2007) · European Radiology · doi:10.1007/s00330-007-0801-0 · Cited by 47
Intracellular role of exchangeable apolipoproteins in energy homeostasis, obesity and non‐alcoholic fatty liver disease
Wu, C., Zhao, S., & Yu, B. (2014) · Biological reviews/Biological reviews of the Cambridge Philosophical Society · doi:10.1111/brv.12116 · Cited by 45
Do obese but metabolically normal women differ in intra-abdominal fat and physical activity levels from those with the expected metabolic abnormalities? A cross-sectional study
Hayes, L., Pearce, M. S., Firbank, M., Walker, M., Taylor, R., & Unwin, N. C. (2010) · BMC Public Health · doi:10.1186/1471-2458-10-723 · Cited by 47
The effects of PCB126 on intra-hepatic mechanisms associated with non alcoholic fatty liver disease
Boucher, M. E., Lefèbvre, C., & Chapados, N. A. (2015) · Journal of Diabetes & Metabolic Disorders · doi:10.1186/s40200-015-0218-2 · Cited by 45
Translating aetiological insight into sustainable management of type 2 diabetes
Taylor, R., & Barnes, A. C. (2017) · Diabetologia · doi:10.1007/s00125-017-4504-z · Cited by 46
PSD3 downregulation confers protection against fatty liver disease
Mancina, R. M., Sasidharan, K., Lindblom, A., Wei, Y., Ciociola, E., Jamialahmadi, O., Pingitore, P., Andréasson, A., Pellegrini, G., Baselli, G., et al. (2022) · Nature Metabolism · doi:10.1038/s42255-021-00518-0 · Cited by 45
Self-citation
The effect of statin alone or in combination with ezetimibe on postprandial lipoprotein composition in obese metabolic syndrome patients
Hajer, G. R., Dallinga‐Thie, G. M., van der Zee, L. C. V. V. –., & Visseren, F. L. J. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.04.035 · Cited by 45
Hepatic PGC-1β Overexpression Induces Combined Hyperlipidemia and Modulates the Response to PPARα Activation
Lelliott, C. J., Ljungberg, A., Ahnmark, A., William‐Olsson, L., Ekroos, K., Elmgren, A., Arnerup, G., Shoulders, C. C., Oscarsson, J., & Lindén, D. (2007) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.107.155739 · Cited by 44
Independent associations between liver fat, visceral adipose tissue, and metabolic risk factors in men
McMillan, K. P., Kuk, J. L., Church, T. S., Blair, S. N., & Ross, R. L. (2007) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/h06-112 · Cited by 45
Hepatic ABCA1 and VLDL triglyceride production
Liu, M., Chung, S., Shelness, G. S., & Parks, J. S. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2011.09.020 · Cited by 43
Mechanisms of action for arsenic in cardiovascular toxicity and implications for risk assessment
Sidhu, M. S., Desai, K. P., Lynch, H. N., Rhomberg, L. R., Beck, B. D., & Venditti, F. J. (2015) · Toxicology · doi:10.1016/j.tox.2015.02.008 · Cited by 43
Hepatic lipogenesis and a marker of hepatic lipid oxidation, predict postprandial responses of triglyceride‐rich lipoproteins
Matikainen, N., Adiels, M., Söderlund, S., Stennabb, S., Ahola, T. M., Hakkarainen, A., Borén, J., & Taskinen, M. (2014) · Obesity · doi:10.1002/oby.20781 · Cited by 43
Self-citation
Serum TG-lowering properties of plant sterols and stanols are associated with decreased hepatic VLDL secretion
Schonewille, M., Brufau, G., Shiri‐Sverdlov, R., Groen, A. K., & Plat, J. (2014) · Journal of Lipid Research · doi:10.1194/jlr.m052407 · Cited by 42
Fenofibrate Increases Very Low Density Lipoprotein Triglyceride Production Despite Reducing Plasma Triglyceride Levels in APOE*3-Leiden.CETP Mice
Bijland, S., Pieterman, E. J., Maas, A. C. E., van der Hoorn, J. W. A., van Erk, M. J., van Klinken, J. B., Havekes, L. M., van Dijk, K. W., Princen, H. M. G., & Rensen, P. C. N. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.123992 · Cited by 41
Hypertriglyceridemic waist phenotype is associated with decreased insulin sensitivity and incident diabetes in elderly men
Carlsson, A., Risérus, U., & Ärnlöv, J. (2014) · Obesity · doi:10.1002/oby.20434 · Cited by 35
Dietary sweet cherry anthocyanins attenuates diet-induced hepatic steatosis by improving hepatic lipid metabolism in mice
Song, H., Wu, T., Xu, D., Chu, Q., Lin, D., & Zheng, X. (2016) · Nutrition · doi:10.1016/j.nut.2016.01.007 · Cited by 41
Vitamin E sequestration by liver fat in humans
Violet, P.-C., Ebenuwa, I., Wang, Y., Niyyati, M., Padayatty, S. J., Head, B., Wilkins, K. J., Chung, S., Thakur, V., Ulatowski, L. M., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.133309 · Cited by 45
Effects of liraglutide on the metabolism of triglyceride-rich lipoproteins in type 2 diabetes
Taskinen, M., Björnson, E., Matikainen, N., Söderlund, S., Pietiläinen, K. H., Ainola, M., Hakkarainen, A., Lundbom, N., Fuchs, J., Thorsell, A., et al. (2021) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.14328 · Cited by 40
Self-citation
Surveillance of the liver in type 2 diabetes: important but unfeasible?
Qadri, S. U., & Yki‐Järvinen, H. (2024) · Diabetologia · doi:10.1007/s00125-024-06087-7 · Cited by 45
Self-citation
Comparative Nontargeted Profiling of Metabolic Changes in Tissues and Biofluids in High-Fat Diet-Fed Ossabaw Pig
Hanhineva, K., Barri, T., Kolehmainen, M., Pekkinen, J., Pihlajamäki, J., Vesterbacka, A., Solano-Aguilar, G. I., Mykkänen, H. M., Dragsted, L. O., Urban, J. F., et al. (2013) · Journal of Proteome Research · doi:10.1021/pr400257d · Cited by 41
Apolipoprotein B Secretion Is Regulated by Hepatic Triglyceride, and Not Insulin, in a Model of Increased Hepatic Insulin Signaling
Moon, B. C., Hernández‐Ono, A., Stiles, B. L., Wu, H., & Ginsberg, H. N. (2011) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.111.241356 · Cited by 41
Transplantation or removal of intra-abdominal adipose tissue prevents age-induced glucose insensitivity
Foster, M. T., Shi, H., Seeley, R. J., & Woods, S. C. (2010) · Physiology & Behavior · doi:10.1016/j.physbeh.2010.05.014 · Cited by 40
Nonalcoholic fatty liver disease associated with metabolic syndrome: Influence of liver fibrosis stages on characteristics of very low-density lipoproteins
Lucero, D., Miksztowicz, V., Gualano, G., Longo, C., Landeira, G., Álvarez, E., Zago, V., Brites, F. D., Berg, G. A., Fassio, E., et al. (2017) · Clinica Chimica Acta · doi:10.1016/j.cca.2017.08.006 · Cited by 38
Reversal and Remission of T2DM – An Update for Practitioners
Shibib, L., Al-Qaisi, M., Ahmed, A. R., Miras, A. D., Nott, D., Pelling, M., Greenwald, S. E., & Guess, N. D. (2022) · Vascular Health and Risk Management · doi:10.2147/vhrm.s345810 · Cited by 41
Impaired Insulin Suppression of VLDL-Triglyceride Kinetics in Nonalcoholic Fatty Liver Disease
Poulsen, M. K., Nellemann, B., Stødkilde-Jørgensen, H., Pedersen, S. B., Grønbæk, H., & Nielsen, S. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-3476 · Cited by 39
Decrease in circulating fibroblast growth factor 21 after an oral fat load is related to postprandial triglyceride-rich lipoproteins and liver fat
Matikainen, N., Taskinen, M., Stennabb, S., Lundbom, N. M. I., Hakkarainen, A., Vaaralahti, K., & Raivio, T. (2011) · European Journal of Endocrinology · doi:10.1530/eje-11-0783 · Cited by 39
Self-citation
Synergistic effects of fructose and glucose on lipoprotein risk factors for cardiovascular disease in young adults
Hieronimus, B., Medici, V., Bremer, A. A., Lee, V., Nuñez, M. V., Sigala, D. M., Keim, N. L., Havel, P. J., & Stanhope, K. L. (2020) · Metabolism · doi:10.1016/j.metabol.2020.154356 · Cited by 41
Incretin based therapies: A novel treatment approach for non-alcoholic fatty liver disease
Blaslov, K. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i23.7356 · Cited by 39
Statins in Nonalcoholic Fatty Liver Disease and Steatohepatitis: Updated Review
Nseir, W., & Mahamid, M. (2013) · Current Atherosclerosis Reports · doi:10.1007/s11883-012-0305-5 · Cited by 38
Pro-inflammatory and atherogenic circulating factors in non-alcoholic fatty liver disease associated to metabolic syndrome
Lucero, D., Zago, V., Lopez, G. I., Graffigna, M. N., Fainboim, H. A., Miksztowicz, V., Meroño, T., Belli, S., Levalle, O. A., Wikinski, R. L. W., et al. (2010) · Clinica Chimica Acta · doi:10.1016/j.cca.2010.09.025 · Cited by 38
Impact of liver fat on the differential partitioning of hepatic triacylglycerol into VLDL subclasses on high and low sugar diets
Umpleby, A. M., Shojaee‐Moradie, F., Fielding, B. A., Li, X., Marino, A., Jawad, N. M. M., Isherwood, C., Jackson, N., Ahmad, A., Stolinski, M., et al. (2017) · Clinical Science · doi:10.1042/cs20171208 · Cited by 41
Changes on serum and hepatic lipidome after a chronic cadmium exposure in Wistar rats
Sarmiento-Ortega, V. E., Treviño, S., Flores-Hernández, J. Á., Aguilar‐Alonso, P., Moroni-González, D., Aburto-Luna, V., Díaz, A., & Brambila, E. (2017) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2017.10.003 · Cited by 37
Association between abdominal adiposity and subclinical measures of left-ventricular remodeling in diabetics, prediabetics and normal controls without history of cardiovascular disease as measured by magnetic resonance imaging: results from the KORA-FF4 Study
Schlett, C. L., Lorbeer, R., Arndt, C., Auweter, S., Machann, J., Hetterich, H., Linkohr, B., Rathmann, W., Peters, A., & Bamberg, F. (2018) · Cardiovascular Diabetology · doi:10.1186/s12933-018-0721-0 · Cited by 39
Steatosis in the Liver
Wang, D. Q. ‐., Portincasa, P., & Neuschwander‐Tetri, B. A. (2013) · Comprehensive physiology · doi:10.1002/cphy.c130001 · Cited by 41
Biosynthesis and Metabolism of ApoB-Containing Lipoproteins
Borén, J., Taskinen, M., & Packard, C. J. (2024) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-062222-020716 · Cited by 46
Self-citation
Chokeberry attenuates the expression of genes related to de novo lipogenesis in the hepatocytes of mice with nonalcoholic fatty liver disease
Park, H., Liu, Y., Kim, H.-S., & Shin, J.-H. (2015) · Nutrition Research · doi:10.1016/j.nutres.2015.10.010 · Cited by 37
Treatment of Rats with a Self-Selected Hyperlipidic Diet, Increases the Lipid Content of the Main Adipose Tissue Sites in a Proportion Similar to That of the Lipids in the Rest of Organs and Tissues
Romero, M. D. M., Roy, S., Pouillot, K., Feito, M., Esteve, M., Grasa, M., Fernández–Löpez, J., Alemany, M., & Remesar, X. (2014) · PLoS ONE · doi:10.1371/journal.pone.0090995 · Cited by 37
Studying non-alcoholic fatty liver disease: the ins and outs of in vivo, ex vivo and in vitro human models
Green, C., Parry, S. A., Gunn, P. J., Ceresa, C. D. L., Rosqvist, F., Piché, M., & Hodson, L. (2018) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2018-0038 · Cited by 40
Impact of NAFLD and its pharmacotherapy on lipid profile and CVD
Wang, Z., Ye, M., Zhang, X., Zhang, P., Cai, J., Li, H., & She, Z. (2022) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2022.07.010 · Cited by 39
Alanine aminotransferase and gamma-glutamyl transferase are associated with the metabolic syndrome but not with angiographically determined coronary atherosclerosis
Saely, C. H., Vonbank, A., Rein, P., Woess, M., Beer, S., Aczél, S., Jankovic, V., Boehnel, C., Risch, L., & Drexel, H. (2008) · Clinica Chimica Acta · doi:10.1016/j.cca.2008.07.024 · Cited by 36
Synthesis of Fructose Biosensors and Progressing Their Efficiency Using Californium Colloidal Nanoparticles for Detecting Fructose and Triglycerides
Heidari, A. (2020) · Advanced Science Engineering and Medicine · doi:10.1166/asem.2020.2635 · Cited by 36
A Differential Network Approach to Exploring Differences between Biological States: An Application to Prediabetes
Valcárcel, B., Würtz, P., al Basatena, N.-K. S., Tukiainen, T., Kangas, A. J., Soininen, P., Järvelin, M., Ala‐Korpela, M., Ebbels, T. M. D., & Iorio, M. D. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024702 · Cited by 35
An endocrine perspective of nonalcoholic fatty liver disease (NAFLD)
Lomonaco, R., Chen, J., & Cusi, K. J. (2011) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018811419157 · Cited by 37
Indian Injection Technique Study: Injecting Complications, Education, and the Health Care Professional
Kalra, S., Mithal, A., Sahay, R. K., John, M., Unnikrishnan, A., Saboo, B., Ghosh, S. K., Sanyal, D., Hirsch, L. J., Gupta, V., et al. (2017) · Diabetes Therapy · doi:10.1007/s13300-017-0244-9 · Cited by 36
The Effect of Zinc Supplementation on Steatosis Severity and Liver Function Enzymes in Overweight/Obese Patients with Mild to Moderate Non-alcoholic Fatty Liver Following Calorie-Restricted Diet: a Double-Blind, Randomized Placebo-Controlled Trial
Fathi, M., Alavinejad, P., Haidari, Z., & Amani, R. (2020) · Biological Trace Element Research · doi:10.1007/s12011-019-02015-8 · Cited by 31
Decreased whole body lipolysis as a mechanism of the lipid-lowering effect of pioglitazone in type 2 diabetic patients
Gastaldelli, A., Casolaro, A., Ciociaro, D., Frascerra, S., Nannipieri, M., Buzzigoli, E., & Ferrannini, E. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90960.2008 · Cited by 37
Hepatic Fatty Acid Balance and Hepatic Fat Content in Humans With Severe Obesity
Lytle, K. A., Bush, N. C., Triay, J. M., Kellogg, T. A., Kendrick, M. L., Swain, J. M., Gathaiya, N. W., Hames, K. C., & Jensen, M. D. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-00875 · Cited by 35
Reproducibility of glucose, fatty acid and VLDL kinetics and multi-organ insulin sensitivity in obese subjects with non-alcoholic fatty liver disease
Magkos, F., Fabbrini, E., Korenblat, K., Okunade, A. L., Patterson, B. W., & Klein, S. J. (2010) · International Journal of Obesity · doi:10.1038/ijo.2010.265 · Cited by 38
Adiponectin gene polymorphisms as a predictor for development of type 2 diabetes mellitus in Iraqi population
Hussain, M. K., Deli, F. A., Algenabi, A. H. A., & Abdul-Rudha, K. H. (2018) · Gene · doi:10.1016/j.gene.2018.03.087 · Cited by 35
E4orf1 Improves Lipid and Glucose Metabolism in Hepatocytes: A Template to Improve Steatosis & Hyperglycemia
Dhurandhar, E. J., Krishnapuram, R., Hegde, V. K., Dubuisson, O. S., Tao, R., Dong, X. C., Ye, J., & Dhurandhar, N. V. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047813 · Cited by 35
Fructose and metabolic health: governed by hepatic glycogen status?
Hengist, A., Koumanov, F., & Gonzalez, J. T. (2019) · The Journal of Physiology · doi:10.1113/jp277767 · Cited by 36
Pancreas–Liver–Adipose Axis: Target of Environmental Cadmium Exposure Linked to Metabolic Diseases
Moroni-González, D., Sarmiento-Ortega, V. E., Díaz, A., Brambila, E., & Treviño, S. (2023) · Toxics · doi:10.3390/toxics11030223 · Cited by 34
Mathematical modelling of hepatic lipid metabolism
Pratt, A. C., Wattis, J. A. D., & Salter, A. M. (2015) · Mathematical Biosciences · doi:10.1016/j.mbs.2014.12.012 · Cited by 34
Bromelain Confers Protection Against the Non-Alcoholic Fatty Liver Disease in Male C57BL/6 Mice
Hu, P.-A., Chen, C.-H., Guo, B., Kou, Y. R., & Lee, T. (2020) · Nutrients · doi:10.3390/nu12051458 · Cited by 35
Kinetic studies to investigate lipoprotein metabolism
Borén, J., Taskinen, M., & Adiels, M. (2011) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2011.02497.x · Cited by 37
Self-citation
Very-low-density lipoprotein mediates transcriptional regulation of aldosterone synthase in human adrenocortical cells through multiple signaling pathways
Saha, S., Bornstein, S. R., Graessler, J., & Kopprasch, S. (2012) · Cell and Tissue Research · doi:10.1007/s00441-012-1346-3 · Cited by 34
Apolipoprotein E4 Exaggerates Diabetic Dyslipidemia and Atherosclerosis in Mice Lacking the LDL Receptor
Johnson, L. A., Arbonés-Mainar, J. M., Fox, R. G., Pendse, A. A., Altenburg, M. K., Kim, H., & Maeda, N. (2011) · Diabetes · doi:10.2337/db11-0466 · Cited by 34
Therapeutic regulation of apoB100 metabolism in insulin resistance in vivo
Watts, G. F., Ooi, E. M. M., & Chan, D. C. (2009) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2009.04.005 · Cited by 33
Portal vein and systemic adiponectin concentrations are closely linked with hepatic glucose and lipoprotein kinetics in extremely obese subjects
Magkos, F., Fabbrini, E., Patterson, B. W., Eagon, J. C., & Klein, S. (2011) · Metabolism · doi:10.1016/j.metabol.2011.03.019 · Cited by 33
Retinol-Binding Protein 4 Is an Independent Factor Associated With Triglycerides and a Determinant of Very Low-Density Lipoprotein–Apolipoprotein B100 Catabolism in Type 2 Diabetes Mellitus
Vergès, B. L., Guiu, B., Cercueil, J., Duvillard, L., Robin, I., Buffier, P., Bouillet, B., Aho, S., Brindisi, M., & Petit, J. (2012) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.112.255190 · Cited by 33
Complex effects of inhibiting hepatic apolipoprotein B100 synthesis in humans
Reyes‐Soffer, G., Moon, B. C., Hernández‐Ono, A., Dionizovik-Dimanovski, M., Jimenez, J., Obunike, J. C., Thomas, T. A., Ngai, C. I., Fontanez, N., Donovan, D. S., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aad2195 · Cited by 33
Genetic variation in human carboxylesterase CES1 confers resistance to hepatic steatosis
Lian, J., Bahitham, W., Panigrahi, R., Nelson, R., Li, L., Watts, R., Thiesen, A., Lemieux, M. J., & Lehner, R. S. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2018.04.002 · Cited by 33
Small dense LDL cholesterol measured by homogeneous assay in Japanese healthy controls, metabolic syndrome and diabetes patients with or without a fatty liver
Kikkawa, K., Nakajima, K., Shimomura, Y., Tokita, Y., Machida, T., Sumino, H., & Murakami, M. (2014) · Clinica Chimica Acta · doi:10.1016/j.cca.2014.07.017 · Cited by 33
Does non-alcoholic fatty liver impair alterations of plasma lipoproteins and associated factors in metabolic syndrome?
Lucero, D., Zago, V., Lopez, G. I., Graffigna, M. N., López, G. H., Fainboim, H. A., Miksztowicz, V., Rosso, L. A. G., Belli, S., Levalle, O. A., et al. (2010) · Clinica Chimica Acta · doi:10.1016/j.cca.2010.12.012 · Cited by 33
Hepatic VLDL assembly is disturbed in a rat model of nonalcoholic fatty liver disease: is there a role for dietary coenzyme Q?
Cano, A., Ciaffoni, F., Safwat, G. M., Aspichueta, P., Ochoa, B., Bravo, E., & Botham, K. M. (2009) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00297.2009 · Cited by 33

Authors: Adiels, M., Taskinen, M.-R., Packard, C., Caslake, M. J., Soro-Paavonen, A., Westerbacka, J., Vehkavaara, S., Häkkinen, A., Olofsson, S.-O., Yki-Järvinen, H., & Borén, J.
Affiliations: University of Gothenburg (SE)
University of Helsinki (FI)
Glasgow Royal Infirmary (GB)
Sahlgrenska University Hospital (SE)
Corresponding author: Borén, J.
ORCID: Adiels, M.
Taskinen, M.-R.
Packard, C.
Häkkinen, A.
Borén, J.
Venue: Diabetologia
Publisher: Springer Science and Business Media LLC
Published: 2006-02-04
Volume: 49
Issue: 4
Pages: 755-765
ISSN: 0012-186X (ISSN-L)
1432-0428
DOI: 10.1007/s00125-005-0125-z
OpenAlex: W2051999166
Cited by: 690
References: 53
Citations by year: 2026: 15 · 2025: 26 · 2024: 29 · 2023: 21 · 2022: 35 · 2021: 29 · 2020: 40 · 2019: 31 · 2018: 27 · 2017: 27 · 2016: 37 · 2015: 41 · 2014: 41 · 2013: 45 · 2012: 38
FWCI: 26.66
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.springer.com/tdm (tdm)
Locations: Diabetologia (publishedVersion)
PubMed (publishedVersion)
Chalmers Research (Chalmers University of Technology) (submittedVersion)
Funders: Helsingin ja Uudenmaan Sairaanhoitopiiri
Göran Gustafssons Stiftelser
Hjärt-Lungfonden
Vetenskapsrådet
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Keywords: hepatic fat content, adiponectin, apolipoprotein B, triglyceride kinetics, type 2 diabetes, insulin resistance, intra-abdominal fat, dyslipidemia
MeSH terms: Adipose Tissue, Adult, Aged, Apolipoproteins B, Diabetes Mellitus, Type 2, Fatty Liver, Humans, Lipoproteins, VLDL, Male, Middle Aged

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Overproduction of large VLDL particles is driven by increased liver fat content in man

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks